Project Grant R01AI195769
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Iowa State University of Science and Technology a Project Grant of $420,750 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 6, 2025, with completion targeted for July 31, 2027. This research initiative investigates the molecular mechanisms of gamete fusion in the malaria parasite (Plasmodium falciparum), with the ultimate objective of identifying...
- Federal Grant Award Summary Iowa State University of Science and Technology received a $385,816 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 24, 2025, with completion targeted for June 30, 2027. The research initiative focuses on identifying and characterizing proteases responsible for processing PREX—a polyprotein critical to apicoplast DNA replication in Plasmodium...
- Federal Project Grant Award Summary The University of Iowa received a Project Grant award of $183,276 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2027. This award supports biomedical research investigating the mechanisms underlying impaired CD8+ T cell responses in individuals with prior malaria exposure, with specific focus on hemozoin—a blood stage...
- Federal Grant Award Summary Iowa State University of Science and Technology received a $453,063 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 13, 2026 through January 31, 2028. The grant funds research aimed at overcoming innate drug efflux transporter systems in nematode parasites to expand the vulnerability of these parasites to anthelmintic...
- Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant of $107,542 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period September 1, 2025, through August 31, 2027. The award supports investigator-initiated biomedical research examining the differential sorting and trafficking mechanisms of Plasmodium falciparum secreted proteins, with particular focus on how...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Hennepin Healthcare Research Institute $661,037 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a five-year malaria vaccine immunotherapy research project beginning May 1, 2026, and concluding April 30, 2031. The award funds investigation of an interleukin-15 (IL-15) cytokine-based therapeutic approach designed to enhance T cell and B cell immune...
- Federal Project Grant Award Summary The University of Iowa received a $582,699 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2026 through June 30, 2031. This award funds a high-throughput screening initiative to identify broad-spectrum antifungal compounds effective against invasive mold infections (IMIs), which represent a significant cause of morbidity and...
- Federal Project Grant Award Summary The University of Iowa received a $233,250 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 1, 2026 through May 31, 2028. The award funds research to elucidate the differential mechanisms by which interferon (IFN) signaling inhibits Ebola virus (EBOV) glycoprotein-dependent viral entry while showing reduced effectiveness against...
- Federal Grant Award Summary The University of South Florida received a $203,060 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 1, 2026 through March 31, 2028. The research project, "Ecology of Plasmodium Malariae Transmission in Cameroon," will deliver comprehensive epidemiological and entomological surveillance to advance understanding of P....
- Federal Project Grant Award Summary Iowa State University received a $200,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through July 31, 2028. The award supports research to advance viral pathogen diagnostics through the development of novel mathematical and statistical methodologies. Specifically, the project delivers computational and analytical tools...
Iowa State University of Science and Technology received a $578,956 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 13, 2026 through June 30, 2031. The award funds research on the regulation of axoneme assembly during Plasmodium falciparum gametogenesis, with the primary objective of advancing scientific understanding of how flagellated male gametes develop and function during the sexual stage of malaria parasite reproduction. The research addresses critical gaps in knowledge regarding microtubule-associated proteins (MAPs) and their role in axoneme stability and assembly, leveraging the natural structural diversity of axonemes across species to study evolutionary mechanisms. By defining the regulatory pathways that govern axoneme formation in malaria parasites, this project seeks to identify potential vaccine targets directed at gametocytes—sexual stage parasites responsible for malaria transmission to mosquito vectors. The work is conducted at Iowa State University's facilities in Ames, Iowa, and contributes to broader NIAID efforts to develop new therapeutic and preventive strategies against a disease affecting 3.3 billion people globally and responsible for nearly 500,000 deaths annually.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $579.0k | 7/13/26 |